Theoretical rejection of fifty-four antineoplastic drugs by different nanofiltration membranes

The rise of nanofiltration technologies holds great promise for creating more effective and affordable techniques aiming to remove undesirable pollutants from wastewaters. Despite nanofiltration's promising potential in removing antineoplastic drugs from liquid matrices, the limited information on this topic makes it important to estimate the rejection rates for a larger number of compounds, particularly the emerging ones, in order to preview the nanofiltration performance. Aiming to have preliminary estimations of the rejection rates of antineoplastic drugs by nanofiltration, 54 antineoplastic drugs were studied in 5 nanofiltration membranes (Desal 5DK, Desal HL, Trisep TS-80, NF270, and NF50), using a quantitative structure-activity relationship (QSAR) model. While this methodology provides useful and reliable predictions of the rejections of compounds by nanofiltration, particularly for hydrophilic and neutral compounds, it is important to note that QSAR results should always be corroborated by experimental assays, as predictions were confirmed to have their limitations (especially for hydrophobic and charged compounds). Out of the 54 studied antineoplastic drugs, 29 were predicted to have a rejection that could go up to 100%, independent of the membrane used. Nonetheless, there were 2 antineoplastic drugs, fluorouracil and thiotepa, for which negligible removals were obtained (<21%). This study's findings may contribute (i) to the selection of the most appropriate nanofiltration membranes for removing antineoplastic drugs from wastewaters and (ii) to assist in the design of effective treatment approaches for their removal.Open access funding provided by FCT|FCCN (b-on). This research was financially supported by (i) POCI-01-0145-FEDER-031297 (CytoStraTech) - funded by FEDER funds through COMPETE2020 - Programa Operacional Competitividade e Inter nacionalizacao (POCI) and by national funds (PIDDAC) through FCT/MCTES; (ii) UIDB/04750/2020 (EPIUnit) and LA/P/0064/2020 (ITR), funded by national funds through the FCT - Foundation for Science and Technology, I.P.; (iii) LA/P/0045/2020 (ALiCE), Base Fundings UIDB/00511/2020 and UIDP/00511/2020 (LEPABE), funded by national funds through FCT/MCTES (PIDDAC). This work is a result of Agenda Embal-agem do Futuro | + ECOLOGICA + DIGITAL + INCLUSIVA, nr. C644931699-00000 042, investment project nr. 59, financed by the Recovery and Resilience Plan (PRR) and by European Union -NextGeneration EU. Teresa I. A. Gouveia also received Ph.D.& grant (SFRH/BD/147301/2019) from the Portuguese Foundation for Science and Technology (FCT)

Adsorption Technologies for the Removal of Cytostatics in Water: A Review

One of the most common treatments for cancer disease requires the administration of cytostatics, which are very effective drugs in the elimination of cancerous cells, but are toxic for healthy tissues. After being administered to patients, they are excreted and frequently reach natural water bodies, due to their poor degradation in wastewater treatment plants (WWTPs), posing a global threat to the environment and human health. The study of proper treatment approaches for the effective removal of these hazardous drugs in WWTPs is thus a topic of concern and of utmost importance to ensure environmental integrity, resilience and sustainability. The aim of this work is to perform a comprehensive review of the application of adsorption-based processes for the treatment of aqueous matrices contaminated with cytostatics, which has never been addressed before. A detailed discussion on the operating conditions, type and concentrations of sorbents used, toxicity of the effluents and other relevant parameters is presented. This paper aims to help identify the most promising sorbents and conditions, the current knowledge gaps, and future challenges/perspectives on adsorption technologies (isolated or coupled with other processes) to tackle the problem of cytostatic fingerprints in water courses. Additionally, information concerning the implementation of these technologies from an environmental and economic (life cycle assessment) perspective is given.This research was funded by: Project POCI-01-0145-FEDER-031297 (CytoStraTech)—funded by the FEDER funds through COMPETE2020—Programa Operacional Competitividade e Internacionalização (POCI) and by the national funds (PIDDAC) through FCT/MCTES; Base Funding—UIDB/00511/2020 of the LEPABE—Laboratory for Process Engineering, Environment, Biotechnology and Energy; UIDB/04750/2020 (EPIUnit) and LA/P/0064/2020 (ITR), funded by the national funds through the FCT—Foundation for Science and Technology. I.P. Teresa I.A. Gouveia would like to thank the Portuguese Foundation for Science and Technology (FCT) for her PhD grant (SFRH/BD/147301/2019)

Antineoplastic drugs in urban wastewater: Occurrence, nanofiltration treatment and toxicity screening*

Antineoplastic drugs are pharmaceuticals that have been raising concerns among the scientific community due to: (i) their increasing prescription in the fight against the disease of the twentieth century (cancer); (ii) their recalcitrance to conventional wastewater treatments; (iii) their poor environmental biodegradability; and (iv) their potential risk to any eukaryotic organism. This emerges the urgency in finding solutions to mitigate the entrance and accumulation of these hazardous chemicals in the environment. Advanced oxidation processes (AOPs) have been taken into consideration to improve the degradation of antineoplastic drugs in wastewater treatment plants (WWTPs), but the formation of by-products that are more toxic or exhibit a different toxicity profile than the parent drug is frequently reported. This work evaluates the performance of a nanofiltration pilot unit, equipped with a Desal 5DK membrane, in the treatment of real WWTP effluents contaminated (without spiking) with eleven pharmaceuticals, five of which were never studied before. Average removals of 68 & PLUSMN; 23% were achieved for the eleven compounds, with decreasing risks from feed to permeate for aquatic organisms from receiving waterbodies (with the exception of cyclophosphamide, for which a high risk was estimated in the permeate). Aditionally, no significative impact on the growth and germination of three different seeds (Lepidium sativum, Sinapis alba, and Sorghum saccharatum) were determined for permeate matrix in comparison to the control.& nbsp;This research was financially supported by: (i) Project POCI-01-0145-FEDER-031297 (CytoStraTech) -funded by FEDER funds through COMPETE2020-Programa Operacional Competitividade e Internacionalizacao (POCI) and by national funds (PIDDAC) through FCT/MCTES; (ii) NORTE-01-0145-FEDER-000069 (Healthy Waters) co-funded by European Regional Development Fund (ERDF) , through North Portugal Regional Operational Programme (NORTE 2020) , under the PORTUGAL 2020 Partnership Agreement; (iii) UIDB/04750/2020 (EPIUnit) and LA/P/0064/2020 (ITR) , funded by national funds through the FCT-Foundation for Science and Technology, I.P.; (iv) LA/P/0045/2020 (ALiCE) , Base Fundings UIDB/00511/2020 and UIDP/00511/2020 (LEPABE) and UIDB/50020/2020 and UIDP/50020/2020 (LSRE-LCM) , funded by national funds through FCT/MCTES (PIDDAC) . This work was also funded by Fundacao para a Ciencia e Tecnologia/Ministerio da Ciencia, Tecnologia e Ensino Superior (FCT/MCTES, Portugal) through national funds to iNOVA4Health (UIDB/04462/2020 and UIDP/04462/2020) and the Associate Laboratory LS4FUTURE (LA/P/0087/2020) . Teresa I.A. Gouveia and Vanessa Jorge Pereira would like to thank the Portuguese Foundation for Science and Technology (FCT) for Ph.D. (SFRH/BD/147301/2019) and CEECIND/02919/2018 grants, respectively

Nanofiltration combined with ozone-based processes for the removal of antineoplastic drugs from wastewater effluents

Over the past years, there has been an increasing concern about the occurrence of antineoplastic drugs in water bodies. The incomplete removal of these pharmaceuticals from wastewaters has been confirmed by several scientists, making it urgent to find a reliable technique or a combination of techniques capable to produce clean and safe water. In this work, the combination of nanofiltration and ozone (O3)-based processes (NF + O3, NF + O3/H2O2 and NF + O3/H2O2/UVA) was studied aiming to produce clean water from wastewater treatment plant (WWTP) secondary effluents to be safely discharged into water bodies, reused in daily practices such as aquaculture activities or for recharging aquifers used as abstraction sources for drinking water production. Nanofiltration was performed in a pilot-scale unit and O3-based processes in a continuous-flow column. The peroxone process (O3/H2O2) was considered the most promising technology to be coupled to nanofiltration, all the target pharmaceuticals being removed at an extent higher than 98% from WWTP secondary effluents, with a DOC reduction up to 92%. The applicability of the clean water stream for recharging aquifers used as abstraction sources for drinking water production was supported by a risk assessment approach, regarding the final concentrations of the target pharmaceuticals. Moreover, the toxicity of the nanofiltration retentate, a polluted stream generated from the nanofiltration system, was greatly decreased after the application of the peroxone process, which evidences the positive impact on the environment of implementing a NF + O3/H2O2 process